Revenue | ₹0.05Cr |
Net Profits | ₹0.01Cr |
Net Profit Margins | 20.00% |
Bacil Pharma Ltd’s revenue fell -91.07% since last year same period to ₹0.05Cr in the Q2 2025-2026. On a quarterly growth basis, Bacil Pharma Ltd has generated -95% fall in its revenue since last 3-months.
Bacil Pharma Ltd’s net profit fell -97.92% since last year same period to ₹0.01Cr in the Q2 2025-2026. On a quarterly growth basis, Bacil Pharma Ltd has generated -98.51% fall in its net profits since last 3-months.
Bacil Pharma Ltd’s net profit margin fell -76.67% since last year same period to 20.00% in the Q2 2025-2026. On a quarterly growth basis, Bacil Pharma Ltd has generated -70.15% fall in its net profit margins since last 3-months.
The revenue for Bacil Pharma Ltd in the Q2 results 2025 was ₹0.05Cr.
The net profit for Bacil Pharma Ltd in the Q2 results 2025 was ₹0.01Cr.
The net profit margin for Bacil Pharma Ltd in the Q2 results 2025 was 20.00%.
The revenue for Bacil Pharma Ltd in the Q2 results 2024 was ₹0.56Cr.
The net profit for Bacil Pharma Ltd in the Q2 results 2024 was ₹0.48Cr.
The net profit margin for Bacil Pharma Ltd in the Q2 results 2024 was 85.71%.